Clioquinol.
D001565:Benzoates / Q000627:therapeutic use; D007464:Clioquinol / Q000009:adverse effects*; D004338:Drug Combinations; D004345:Drug Industry; D009187:Myelitis / Q000139:chemically induced; D009902:Optic Neuritis / Q000139:chemically induced; D015125:Oxyquinoline / Q000031:analogs & derivatives / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013557:Switzerland; D013577:Syndrome
D001565:Benzoates; D004338:Drug Combinations; D011804:Quinolines; D015125:Oxyquinoline; D007464:Clioquinol